Sustainability Report

Overview

The report highlights Tigermed's 2019 scale and growth, reporting operating revenue of 28.03 RMB 100 million and 4,959 active employees. It describes the company's clinical-research contribution, including participation in 319 Class I Chinese innovative-drug projects and support for 36 drugs approved for market. The report also describes board diversity, with three female directors among six directors after the April 2020 re-election. Environmental indicators are disclosed for three offices, with the report noting that statistics will gradually expand to cover the entire group.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services